CHE Chemed
- 574.130
- +1.420+0.25%
- 573.390
- -0.740-0.13%
Chemed News
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the Encore at the Wynn Las
Chemed Corporation (NYSE:CHE) Q1 2024 Earnings Call Transcript
Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says
Chemed's (CHE) Q1 results were "a rare earnings miss" as its Roto-Rooter unit continued to face pressure in the quarter coupled with ineffective returns on paid advertising, Oppenheimer said in a note
Chemed Corporation Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that Chemed Corporation (NYSE:CHE) released its quarterly result to the market. The early response was not positive, with shares down 4.0% to US$573 in the past week.
Chemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...
Q1 2024 Chemed Corp Earnings Call
Earnings Call Summary | Chemed(CHE.US) Q1 2024 Earnings Conference
The following is a summary of the Chemed Corporation (CHE) Q1 2024 Earnings Call Transcript:Financial Performance:Chemed's subsidiary, VITAS, saw its net revenue rise 14% to $354 million compared to t
Chemed Corporation (CHE) Q1 2024 Earnings Call Transcript
Chemed Corporation (CHE) Q1 2024 Earnings Call Transcript
Chemed Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Chemed Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Chemed (CHE) Receives a Rating Update From a Top Analyst
Analysts' Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
Earnings Not Telling The Story For Chemed Corporation (NYSE:CHE)
With a price-to-earnings (or "P/E") ratio of 34.3x Chemed Corporation (NYSE:CHE) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have P/
Chemed Corp (CHE) Q1 2024 Earnings: Mixed Results Amidst Segment Variances
Chemed Q1 Adjusted Earnings, Revenue Rise -- Shares Down After Hours
Chemed (CHE) reported Q1 adjusted earnings late Wednesday of $5.20 per diluted share, up from $4.28 a year earlier. Four analysts surveyed by Capital IQ expected $5.48. Revenue for the quarter ended M
Chemed Corp. Announces Increase In Q1 Income, but Misses Estimates
Chemed Sees FY24 EPS $23.30-$23.70 Vs $23.52 Est.
Guidance for 2024Management reiterates its estimated full-year 2024 earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related t
Chemed Q1 Adj $5.20 Misses $5.48 Estimate, Sales $589.23M Miss $591.46M Estimate
Chemed (NYSE:CHE) reported quarterly earnings of $5.20 per share which missed the analyst consensus estimate of $5.48 by 5.11 percent. This is a 7.88 percent increase over earnings of $4.82 per share
Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 Revenue $589.2M, Vs. Street Est of $591.1M
04:19 PM EDT, 04/24/2024 (MT Newswires) -- Earnings Flash (CHE) CHEMED CORPORATION Reports Q1 Revenue $589.2M, vs. Street Est of $591.1M
Chemed 1Q Net $65M >CHE
Chemed 1Q Net $65M >CHE
Press Release: Chemed Reports First-Quarter 2024 Results
Chemed Reports First-Quarter 2024 Results CINCINNATI--(BUSINESS WIRE)--April 24, 2024-- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the natio
Analysis
Price Target
No Data
